Ocrelizumab in Patients With Early-stage RRMS-Results from the Phase IIIb ENSEMBLE Trial and the Matched Real-world NTD MS Registry Cohort

Authors
Category Primary study
JournalNeurology
Year 2024
This article has no abstract
Epistemonikos ID: 750e4affce2459c06c196e951be5230085da0f6b
First added on: Feb 19, 2025